financetom
Business
financetom
/
Business
/
ZYUS Life Sciences Amends Promissory Note
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ZYUS Life Sciences Amends Promissory Note
Mar 17, 2025 6:37 AM

09:14 AM EDT, 03/17/2025 (MT Newswires) -- ZYUS Life Sciences ( ZLSCF ) , which rose 5.5% on Friday from near its 52-week low, amended a promissory note agreement.

The promissory note previously entered between its wholly-owned unit ZYUS Life Sciences ( ZLSCF ) and an independent director of the company was also replaced by a loan agreement between the two sides.

The company said the independent director agreed to advance additional cash consideration of $0.25 million, pursuant to the loan. ZYUS added that $0.025 million of accrued but unpaid interest under the promissory note has been capitalized and added to the principal amount of the loan for $0.375 million, increasing the principal amount owing to the independent director from $0.1 million to $0.375 million and extending the maturity date from Aug. 27 to March 28, 2027.

The company said it intends to use proceeds as general working capital.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved